Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
about
Determinants of relapse periodicity in Plasmodium vivax malariaPrimaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionPrimaquine for reducing Plasmodium falciparum transmissionDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaPrimaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquineArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaThe effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient dataA review of mixed malaria species infections in anopheline mosquitoesPrimaquine in vivax malaria: an update and review on management issuesUsing genetic methods to define the targets of compounds with antimalarial activityBlocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysisA head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trialThe use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaOptimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistanceReduced susceptibility of Plasmodium falciparum to artesunate in southern MyanmarBenznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatmentsEfficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studiesA high susceptibility to redox imbalance of the transmissible stages of Plasmodium falciparum revealed with a luciferase-based mature gametocyte assayMolecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesThe effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataAnti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment.Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionDefining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SPEpidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationElimination therapy for the endemic malarias.The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.Primaquine: the risks and the benefitsA quantitative high throughput assay for identifying gametocytocidal compoundsEfficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivaxA malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue
P2860
Q17485692-998B5D48-08CA-4001-957E-0F5DE3F4811EQ24188070-A30CF6D5-69FD-4192-B12B-F48A8CFE7729Q24193716-0A8B06F8-3D5A-4BF4-A60C-43860D6F27EDQ24200471-0099B0D9-53DB-4AE6-937B-8C6EF77E41F8Q24201077-90803314-CE09-47DC-855D-AAB618AA4A64Q24202900-23A2E6D2-2701-43F9-88A4-5C45AEA6CACBQ24202910-7525A229-AC3A-4D65-89AF-70BA2641ED08Q24235351-95C41984-4DD4-4BE9-A507-2BC6B166C4ABQ26822489-47DA38A0-A5B1-4F04-8DAA-D51B56400268Q26862739-57B909F4-ED69-4611-ACC7-AAF444A0C07EQ27003856-BAD4F164-3D7A-42D8-9F51-B44A915C1229Q27014788-9B9A5195-3698-4BF7-8A62-1A33507097D7Q27014789-22491190-68A2-4830-B642-30D430B43FEFQ28477853-9C81097A-F1C0-4142-A3F5-612BE9240F07Q28478579-6AF6A07D-A4D3-4786-8B84-6683BF02C5A7Q28483944-175F4187-9D73-407E-91D3-05BD11E7058CQ28487881-573F4427-8B55-4461-A70B-114D7EFBF431Q28535357-B7139411-BFCA-481D-AED9-ABFD6E44EBCCQ28535686-75C30E2B-7B5F-4924-B479-9391C5CC8E55Q30044470-5A08DD2E-688E-4BE1-88D0-6CCAF00562FFQ30568502-480F39CF-7047-4857-93DD-DC4FFDEDF0ECQ30936416-223B5790-BA0B-498A-81D6-512BEF770F89Q33601120-7817AEAD-C507-4E41-8EF3-117034EFB6F4Q33655603-9311D2CC-CA6A-4C60-AF2E-8C6CD4E7961BQ33713272-40E5848B-0D80-4E9D-A4F6-AEA06657EA78Q33772980-6E756FEB-51F6-4BFB-8140-2500B5860DFDQ33886228-8407B6C0-FF83-462D-97BA-19A2F725BA5BQ33901814-37117FE7-7831-4523-ADDD-FCD43A4343DAQ34020818-43CA025D-DCB9-40E6-B038-1C732F67F9D3Q34149975-E959813C-A7A0-4C00-BF55-29E0C264B3F1Q34177472-B4C4E3B8-AAA6-460F-ABD3-E57C6757EB3BQ34194828-E9930F70-6709-4C65-BA40-CC73189A2C68Q34329292-A9AE8DF2-3849-4CC6-989B-F383245641ABQ34486508-C45B323E-FF74-4091-82FA-6912D6DFE6B9Q34503631-FB474A85-5DA2-4E08-81CB-C1C30E731E7BQ34605248-86CD027E-6E9B-4DA2-9C27-E187D1BCA86DQ34646141-AEEE649D-5ABF-4DCE-BECE-6E81A2F6FA15Q34699136-97CA0396-3AC7-4A8E-A6C9-4265FBA4E8CDQ34772862-9B31608F-036B-43EB-87D8-A7CACFA1370AQ34786064-1211B8DB-3F17-48D8-89AB-605C592DCCF1
P2860
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effectiveness of five artemisi ...... n open-label randomised trial.
@ast
Effectiveness of five artemisi ...... n open-label randomised trial.
@en
Effectiveness of five artemisi ...... n open-label randomised trial.
@nl
type
label
Effectiveness of five artemisi ...... n open-label randomised trial.
@ast
Effectiveness of five artemisi ...... n open-label randomised trial.
@en
Effectiveness of five artemisi ...... n open-label randomised trial.
@nl
prefLabel
Effectiveness of five artemisi ...... n open-label randomised trial.
@ast
Effectiveness of five artemisi ...... n open-label randomised trial.
@en
Effectiveness of five artemisi ...... n open-label randomised trial.
@nl
P2093
P2860
P50
P921
P1476
Effectiveness of five artemisi ...... n open-label randomised trial.
@en
P2093
Arkar Linn Naing
Aung Pyay Phyo Oo
Frank Smithuis
Moe Kyaw Kyaw
Mya Yee Nyo
Naing Zaw Htun Myint
Pyay Phyo Aung
P2860
P304
P356
10.1016/S1473-3099(10)70187-0
P577
2010-09-09T00:00:00Z